Sort
53,477 grants matching “addiction”
Realization of Optical Cell-based Reporters for in vivo Detection of Neuropeptides
$891,384Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · MH
Realization of Optical Cell-based Reporters for in vivo Detection of Neuropeptides
$891,384Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · MH
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)
$890,930Shivanand P Lad · Duke University · UH3 · FY2024 · NS
Optimization of GPCR-based fluorescent sensors for large-scale multiplexed in vivo imaging of neuromodulation
$890,841Samuel Andrew Hires · University Of Southern California · U01 · FY2022 · NS
Endocannabinoid roles in neurochemical and reinforcing effects of abused drugs
$890,697Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2016 · DA
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$890,697Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2016 · DA
Scientific Core
$890,656Amelia M Arria · Treatment Research Institute · P50 · FY2012 · DA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
$890,494John M Littleton · Naprogenix, Inc · R44 · FY2020 · AA
Overdose Risk Management and Compensation in the Era of Naloxone
$890,476Alexander S Bennett · New York University · R01 · FY2021 · DA
NIDA CLINICAL TRIALS NETWORK - NYC EAST SIDE NODE
$890,037New York University School Of Medicine · U10 · FY2005 · DA
All-in-one Device for Forensic Toxicology Drug Screening
$889,695Justin Michael Wiseman · Wik Devices, Llc · R44 · FY2023 · DA
MACC/EPICC-Net as a Hub for the HEAL Initiative EPICC-Net
$889,613Jennifer Lynn Hernandez-Meier · Medical College Of Wisconsin · U24 · FY2019 · NS
Clinical development of mechanism-based lymphoma therapies
$889,551Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Adapting Web-based CBT to improve adherence and outcome for individuals with opioid use disorder and chronic pain treated with opioid agonists
$889,504Alicia Heapy · Yale University · R33 · FY2024 · AT
Pioglitazone for the Treatment of Opioid and of Nicotine Dependence
$889,448Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2012 · DA
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes
$888,550Michael Darin Cameron · Scripps Research Institute, The · U01 · FY2011 · AA
Injectable naltrexone 2-month depot formulations
$888,085Kinam Park · Purdue University · UH3 · FY2022 · DA
Clinical Trials Network: Pacific Northwest Node
$887,722Dennis M Donovan · University Of Washington · UG1 · FY2018 · DA
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD
$887,600Brian Thomas · Research Triangle Institute · N01 · FY2015 · DA
Project 1: Enhancing the Economic Impact Analysis used in FDA's Rules p150-201
$887,455Michael Paul Eriksen · Georgia State University · P50 · FY2014 · DA
Understanding the links between parental and adolescent substance use:complementary natural experiments using the children of twins design
$886,844Soo H Rhee · University Of Colorado · R01 · FY2023 · DA
Dissemination of MAPseq and BARseq for High-Throughput Brain Mapping
$886,690Anthony M Zador · Cold Spring Harbor Laboratory · U24 · FY2025 · NS
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$886,533Frederick Lewis Altice · Yale University · R01 · FY2016 · DA
IGF::OT::IGF: PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932.
$886,385Patrick Beardsley · Virginia Commonwealth University · N01 · FY2018 · DA
AIDS and Opiates: A Monkey Model
$885,932Emory University · R01 · FY2004 · DA